The FDA laid out a proposed new regulatory plan to oversee potentially thousands of laboratory-developed medical tests that the agency contends can be prone to errors.
WSJ.com: US Business, Wall Street Journal: Business
Thu, 07/31/2014 - 3:34pm
The FDA laid out a proposed new regulatory plan to oversee potentially thousands of laboratory-developed medical tests that the agency contends can be prone to errors.